Bridging the Last Mile of Acute Cardiology: Synthesized 3D Vectorcardiography at Home
Dr. Dereck Mush, MD, MBA
HeartBeam
Develops a pocket sized 3D vector ECG system for patient led heart monitoring.
What they do
Develops a credit card sized, personal 12 lead equivalent 3D vector electrocardiogram device. Designed for patients with known coronary artery disease, the platform transmits cardiac data to physicians to help determine if chest pain warrants emergency care. In October 2026 the FDA granted the HeartBeam System Breakthrough Device Designation as a tool for assessing potential heart attacks at home, supported by the 134-patient ALIGN-ACS pilot study.
The record
- Vertical
- Cardiovascular
- Sub-segment
- Personal ECG monitoring
- Product type
- Device
- Stage
- Public
- Headquarters
- Santa Clara, United States
- Region
- North America
- Founded
- 2015
- Total funding
- $25M raised
Notable investors: Keiretsu Forum, Angels.
Also in Cardiovascular
Related on The Signal
Dr. Dereck Mush, MD, MBA
Wearable cardiac monitoring is catching arrhythmias in men who would never have scheduled the test that found them
Dr. Dereck Mush, MD, MBA
The ECG-to-Echo Pathway: Where Tempus ECG-MR Must Prove Its Value
Dr. Dereck Mush, MD, MBA
Hardware Tiering and AI Coaching: How Google's Fitbit Edge Reshapes Continuous Monitoring Economics
Dr. Dereck Mush, MD, MBA